Eurofins Bioanalytical Services, a division of Eurofins Clinical Trial Solutions, is a biologics-focused, global leader in bioanalytical solutions providing over 20 years of industry-leading scientific expertise.
We specialize in comprehensive PK/TK, ADA, NAb, biomarker assays, and sample analysis for the world’s largest pharmaceutical and biopharmaceutical companies. We support both clinical and non-clinical studies (GLP/GCP) and are CLIA licensed.
Our mission is to extend our clients' capabilities of improving global health by combining scientific knowledge, capacity, regulatory expertise, and flexibility to provide the trusted, relevant information required for the drug approval process.
In this webinar, Dr. Virginia Litwin, Director, Scientific Affairs, Eurofins Clinical Trial Solutions, will review the fundamental principles and current best practices for instrument qualification and calibration, assay optimization, and method validation. Updates on on-going standardization efforts from the National Institute of Standards and Technology (NIST) Flow Cytometry Standards Consortium and the recently formed SOULCAP Initiative will also be presented. Plus, the future directions from the International Society for Analytical Cytometry (ISAC) will be introduced.